Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H13N5O4 |
Molecular Weight | 255.2306 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
InChI
InChIKey=IRSCQMHQWWYFCW-UHFFFAOYSA-N
InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)
Molecular Formula | C9H13N5O4 |
Molecular Weight | 255.2306 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:12 UTC 2023
by
admin
on
Fri Dec 15 15:04:12 UTC 2023
|
Record UNII |
P9G3CKZ4P5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
237607
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NCI_THESAURUS |
C1556
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NCI_THESAURUS |
C29575
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VITRASERT IMPLANT (WITHDRAWN: HIV INFECTIONS)
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NDF-RT |
N0000020060
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
LIVERTOX |
NBK548760
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NDF-RT |
N0000175461
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VITRASERT IMPLANT (WITHDRAWN: CYTOMEGALOVIRUS RETINITIS)
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NDF-RT |
N0000175466
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
WHO-VATC |
QS01AD09
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
FDA ORPHAN DRUG |
5885
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
WHO-ATC |
J05AB06
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
WHO-VATC |
QJ05AB06
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
WHO-ATC |
S01AD09
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
FDA ORPHAN DRUG |
86494
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
465284
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
100000085455
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
SUB07881MIG
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
135398740
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
1277
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
W-148
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
DTXSID8041032
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
DB01004
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
1288306
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
C517
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
P9G3CKZ4P5
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
CHEMBL182
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
759656
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
4678
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | RxNorm | ||
|
Ganciclovir
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
6023
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
m5663
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | Merck Index | ||
|
P9G3CKZ4P5
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
6512
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
82410-32-0
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
D015774
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY | |||
|
GANCICLOVIR
Created by
admin on Fri Dec 15 15:04:12 UTC 2023 , Edited by admin on Fri Dec 15 15:04:12 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
Vmax
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
TRANSPORTER -> SUBSTRATE |
Vmax
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 1.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|